Orchid Pharma Ltd.

₹990

-7 (-0.7%)

ORCHPHARMA Share Price

Pharmaceuticals & Biotechnology

As on October 1, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 5,937.92 Cr

P/E Ratio152.08

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,018.04	Bearish
10-DMA	1,046.71	Bearish
20-DMA	1,010.85	Bearish
50-DMA	1,003.15	Bearish
100-DMA	950.48	Bullish
200-DMA	800.08	Bullish

Historical Performance

1 Year

37.5%

3 Years

86.2%

5 Years

131.4%

10 Years

2498.4%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	12,328	13,976	8,194	6,659	5,596
Total Expenditure	12,289	12,598	7,086	5,816	5,050
Other Income	665	389	311	194	90
Operating Profit	703	1,768	1,419	1,037	636
Interest	93	133	167	329	335
Depreciation	432	420	332	548	870
Profit Before Tax	104	1,215	919	552	-569
Consolidated Net Profit	100	1,351	922	463	-20
Adjusted EPS	7	88	18	11	---

Compounded Sales Growth

10 Years:7.1

5 Years:22.3

3 Years:13.1

TTM:-2.5

Compounded Profit Growth

10 Years:-58.5

5 Years:-50.5

3 Years:-26.5

TTM:-40.6

Stock Price CAGR

10 Years:38.1

5 Years:18.3

3 Years:24.3

TTM:33.1

Return on Equity

10 Years:-55.1

5 Years:-0.5

3 Years:18.2

last year:6.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	153	153	507	408	408
Total Reserves	15,044	14,940	11,187	6,478	6,066
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,026	147	1,244	1,647	2,224
Other Current Liabilities	558	266	143	531	472
Short Term Borrowings	879	1,430	140	1,410	228
Total Liabilities	22,581	20,773	15,539	12,252	11,106
Capital Work in Progress	3,405	645	164	465	98
Long Term Loans & Advances	1,564	1,315	664	602	739
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	750	755	574	225	201
Total Current Assets	9,290	10,974	7,908	5,010	3,844
Total Assets	22,581	20,773	15,539	12,252	11,106
Adjusted Book Value	993	987	231	169	159

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 152.08, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 24.3%, indicating sustained price appreciation.
The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹703 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹12328 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1330645.2

No. of Shares: 1344 (Approx)

Performance:33.1%

330645.2

NIFTY Performance: -9.9%

1 day Top Gainers